Clinical Trials and Drug Development of the Future
                     CLINICAL TRIALS AND DRUG 
DEVELOPMENT OF THE FUTURE
INTRODUCTION
CLINICAL TRIALS ARE AT A CROSSROAD. THE INNOVATION OF SCIENCE, 
INFORMATION TECHNOLOGY AND COOPERATION BETWEEN COUNTRIES 
TRANSFORMS THE WAY DRUGS ARE DELIVERED TO CLIENTS. AND THIS 
CHANGE IN ALL ASPECTS OF THE PROCESS, IN ITS EARLY PLANNING, PATIENT 
RECRUITMENT, AND LONG-TERM SAFETY MONITORING. LOOKING AT THE 
CLINICAL RESEARCH TRENDS OF THE FUTURE, IT IS ONE THING THAT BECOMES 
CLEAR: THE DEVELOPMENT OF DRUGS IS SHIFTING TO BE FASTER, MORE 
PRECISELY, AND MORE PATIENT-FRIENDLY.
THE TRANSITION TO CLINICAL RESEARCH 
THAT IS DIGITAL-FIRST
TECHNOLOGICAL TOOLS ARE NO LONGER ON THE PERIPHERY. THEY HAVE 
COME TO INFLUENCE THE CONDUCT OF STUDIES. DIGITAL SYSTEMS PROVIDE 
REMOTE MONITORING TO RESEARCH, E-CONSENT, RESEARCH TEAMS, AND 
SIMPLIFY WORK, MINIMIZE ERRORS, AND ENHANCE THE SPEED OF STUDIES. 
THIS TRANSITION SHORTENS THE GAPS BETWEEN THE STAGES OF 
DEVELOPMENT.
DIRECT INFLUENCES ON THE STAGES OF 
CLINICAL DRUG DEVELOPMENT
CLINICAL DEVELOPMENT OF DRUGS GOES THROUGH A NORMAL PROCESS- 
PHASE I, PHASE II, PHASE III, AND PHASE IV. 
• PHASE I: QUICKER, MORE SECURE INITIAL INFORMATION
• PHASE II: BETTER DOSE AND RESPONSE UNDERSTANDING
• PHASE III: PHASE III PHASE III LARGE STUDIES ARE GLOBAL AND ARE EASIER 
TO MANAGE
• PHASE IV: IT IS TIME TO TEST IT IN THE REAL WORLD
THE HISTORY OF CRO CLINICAL RESEARCH
THE POINT IN CONTEMPORARY CLINICAL TRIALS IS THE CROS. THEY ORGANIZE 
SCHEDULES, ORGANIZE INVESTIGATORS, PROCESS DATA, AND PROVIDE 
COMPLIANCE. NEW RESPONSIBILITIES OF CROS IN THE FUTURE ARE EMERGING.
• INFORMATION CONSOLIDATION IS NORMAL
• ADDITIONAL EMPHASIS ON DECENTRALIZED TRIALS
• DETECTION OF NEW DEMANDS ON AI AND AUTOMATION
• THE SPECIALIZATION IN THE THERAPEUTIC AREAS BECOMES MORE SIGNIFICANT
THE DEVELOPMENT OF THERAPEUTIC 
DOMAINS IN RELATION TO NEW RESEARCH 
INSTRUMENTS
VARIOUS CLINICAL TRIAL SPHERES OF THERAPY VARY DIFFERENTLY.
• ONCOLOGY
• NEUROLOGY
• CARDIOLOGY
• RARE DISEASES
• METABOLIC DISORDERS
• EXPANDING ADAPTIVE AND PLATFORM TRIALS
CONCLUSION
THERE IS SIGNIFICANT CHANGE IN THE FUTURE OF CLINICAL TRIALS AND DRUG 
DEVELOPMENT. EVERY ASPECT OF THE PROCESS IS ENHANCED BY THE USE OF 
DIGITAL TOOLS, NEW DATA SOURCES, AND DESIGN THAT IS PATIENT-ORIENTED. 
THE STAGES OF THE CLINICAL DRUG DEVELOPMENT ARE NOT CHANGED, THE 
WAY YOU CONDUCT THEM BECOMES MORE PLIABLE, MORE COMPUTER-LIKE, 
AND MORE EFFECTIVE. 
WEBSITE : WWW.CLIVAL.COM 
• WWW.LIFESCIENCEINTELLIPEDIA.COM 
• WWW.CHEMXPERT.COM
LOCATION:- C-89, SECTOR-65 NOIDA-U.P. 201301 (INDIA)
E-MAIL:- [email protected]  | [email protected] 
PHONE:- +91-120-6631301-335
MOB NO:- +91-9990237670
K 
AN
TH U!
YO